BR100 Decreased By (-0.4%)
BR30 Decreased By (-0.65%)
KSE100 Decreased By (-0.29%)
KSE30 Decreased By (-0.22%)
AGHA 6.58 Decreased By ▼ -0.09 (-1.35%)
BECO 4.38 Increased By ▲ 0.03 (0.69%)
BML 55.53 Decreased By ▼ -0.64 (-1.14%)
BOP 29.93 Decreased By ▼ -0.19 (-0.63%)
CNERGY 12.72 Decreased By ▼ -0.26 (-2%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.13 Decreased By ▼ -0.52 (-1.01%)
FFL 14.41 Decreased By ▼ -0.08 (-0.55%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 5.97 Decreased By ▼ -0.09 (-1.49%)
KOSM 5.57 Decreased By ▼ -0.27 (-4.62%)
LOTCHEM 26.25 Increased By ▲ 0.08 (0.31%)
MLCF 90.14 Decreased By ▼ -1.09 (-1.19%)
NBP 162.11 Decreased By ▼ -2.08 (-1.27%)
NCPL 52.62 Decreased By ▼ -0.56 (-1.05%)
NPL 57.98 Decreased By ▼ -1.14 (-1.93%)
OGDC 314.62 Increased By ▲ 1.23 (0.39%)
PACE 9.70 Decreased By ▼ -0.07 (-0.72%)
PAEL 34.77 Decreased By ▼ -0.47 (-1.33%)
PIBTL 14.20 Decreased By ▼ -0.51 (-3.47%)
PPL 220.66 Decreased By ▼ -0.70 (-0.32%)
PRL 90.35 Decreased By ▼ -0.87 (-0.95%)
PTC 58.87 Decreased By ▼ -0.32 (-0.54%)
SSGC 23.27 Decreased By ▼ -0.03 (-0.13%)
TBL 8.67 Decreased By ▼ -0.08 (-0.91%)
TELE 7.36 Decreased By ▼ -0.25 (-3.29%)
TPL 21.02 Decreased By ▼ -1.01 (-4.58%)
TPLP 12.10 Decreased By ▼ -0.46 (-3.66%)
TREET 21.36 Decreased By ▼ -0.37 (-1.7%)
TRG 54.39 Decreased By ▼ -1.40 (-2.51%)
By

London’s FTSE 100 slipped on Monday, weighed down by the pharmaceutical and energy sectors, while investor optimism around a highly anticipated interest rate cut by the European Central Bank in this week’s policy decision contained declines.

The blue-chip FTSE 100 index closed down 0.2%, while the mid-cap FTSE 250 advanced 0.8% in its third session of gains.

The pharma and biotech sector slumped 1.5%, after hitting an over one-month low during the day. Drugmaker GSK sank 9.5% to the bottom of the FTSE 100 after a Delaware ruling allowed more than 70,000 lawsuits to proceed over GSK’s discontinued heartburn drug Zantac.

Energy stocks also lost 1.2%, in tandem with oil prices, which slipped over $2 per barrel.

Declines in the market were contained by broader gains on investor optimism ahead of the ECB’s meeting later this week, where it is expected to commence its interest rate cutting cycle.

London stocks edge higher ahead of ECB rate decision; GSK slumps

A survey from the Institute for Supply Management showed slowing U.S. manufacturing activity in May, fuelling some expectations of a September rate cut from the Federal Reserve.

“There is increased optimism of interest rate cuts as we head towards the ECB meeting, and U.S. manufacturing data adding to signs that consumers are reining in their spending,” said Fiona Cincotta, senior market analyst at City Index.

Analysts predict the Bank of England (BoE) will closely shadow the ECB’s movements. However, traders have priced in a 25-basis-point cut by the BoE only in November.

“The Bank of England will (not) necessarily be taking decisions on what the ECB is doing, given that this (decision) might be a cut and then a pause rather than the start of back-to-back cuts,” Cincotta added.

A separate survey showed British manufacturers reported a return to growth in May, but higher prices charged by firms could add to the BoE’s caution around cutting rates.

Among other stocks, JD Sports Fashion jumped 5.1% topping the FTSE 100, after a 4.7% slump on Friday.

Comments

Comments are closed for this article.